RHCG and neoplasm: Recently, promoter hypermethylation of CHL1 and RHCG, two novel tumor suppressor candidates, has been reported to be associated with poor differentiation and increased invasion of ESCC, as well as advanced tumor stage and decreased overall survival (48, 49).